A PARP inhibitor, rucaparib, improves cardiac dysfunction in ADP-ribose-acceptor hydrolase 3 (Arh3) deficiency https://www.biorxiv.org/content/10.1101/2023.02.07.527369v1?med=mas
A PARP inhibitor, rucaparib, improves cardiac dysfunction in ADP-ribose-acceptor hydrolase 3 (Arh3) deficiency https://www.biorxiv.org/content/10.1101/2023.02.07.527369v1?med=mas